Australia's stock exchange operator has admitted it misled the market about the status of its long-running CHESS replacement project, setting the stage for a proposed $13.3 million (AUD $20.5 million) penalty and a further $1.95 million (AUD $3 million) contribution toward regulatory costs.
Tönnies Unternehmensbeteiligungen has been fined €1.15 million by Austria's Cartel Court after completing an acquisition months before notifying competition authorities, despite the deal ultimately receiving regulatory approval. The penalty stems from Tönnies' acquisition of a shareholding in Ritzenhoff, a manufacturer and distributor of glass and ceramic products. According to the Austrian Federal Competition Authority (AFCA), the transaction was completed on September 6, 2023. The company did not notify Austrian regulators until April 16, 2024.
The Federal Court of Australia has imposed $193 million (AUD $300.2 million) in penalties against collapsed contracts-for-difference issuer Union Standard International Group and two former authorized representatives after finding they engaged in systemic unconscionable conduct that left customers with losses exceeding $53 million (AUD $83 million).
Marketing disclosures are often treated as the final step in a product launch. A disclaimer is added, compliance signs off, the campaign goes live, and attention moves elsewhere. The Malta Financial Services Authority's latest supervisory review suggests that approach remains more common than regulators would like.
Brazil's antitrust authority has fined Japanese automotive supplier Denso Corporation approximately $19.5 million (100.8 million reais), concluding a case that traces back more than a decade and centers on allegations of coordinated conduct in the market for wire harnesses and other automotive electrical components.
The Italian Competition Authority has fined Philip Morris €7 million after finding that the company's advertising for combustion-free tobacco products misled consumers into believing the products were harmless to health or less harmful than other tobacco products.
A discount program is supposed to lower the price of a prescription. The dispute at the center of a newly announced $40 million settlement is what happens when those discounts exist for customers but are not reflected in the prices reported to government healthcare programs.